Dynavax Technologies


Dynavax Technologies Stock Quote
$5.66 -$0.12 -2.0%
BATS BZX Real Time Price as of January 23, 2020, 12:43 p.m. EST View Interactive DVAX Charts

A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.

News & Analysis: Dynavax Technologies

The Fool has written over 100 articles on Dynavax Technologies.


Market Moves


Is Dynavax Technologies a Buy?

Dynavax's stock surged higher in August. Can this small-cap biotech keep churning higher?

Interactive Chart